Temperature control pressing treatment device

Abstract

The invention discloses a temperature control pressing treatment device which comprises a host and a pressing head. The host comprises a host shell, an operation part, a transmission mechanism and a power supply unit; the pressing head comprises a pressing head shell, a pressing block assembly and an eyelid plate; the rear end of the pressing head shell is fixedly connected to the main machine shell, and the eyelid plate is fixedly connected to the front end of the pressing head shell through one or more connecting arms. The pressing block assembly is movably connected into the pressing head shell and can move close to or away from the eyelid plate. A temperature control heating unit for hot compress is further arranged on the front portion of the pressing block assembly. And the transmission mechanism is connected between the operation part and the pressing block assembly and is driven by the operation part to enable the pressing block assembly to move close to or far away from the eyelid plate so as to press the eyelids, and hot compress is performed under the action of the temperature control heating unit. The temperature control pressing treatment device greatly facilitates the operation process of doctors, shortens the treatment time and improves the treatment effect.

Description

technical field [0001] The invention relates to an ophthalmic medical device, in particular to a temperature-controlled pressing therapy device. Background technique [0002] Dry eye disease (dryeyedisease, DED) is a worldwide epidemic ophthalmic disease, according to foreign epidemiological surveys, the United States, South Korea, Singapore, Iran and other countries, the prevalence rate of 12.3% to 18.3%. The population of patients with dry eye is huge, but because there is no standardized treatment plan in clinic, the treatment effect is not ideal. [0003] Meibomian gland dysfunction (Meibomian+gland+dysfunction, MGD) is a major cause of watery-deficient dry eye and is characterized by obstruction of glandular terminal ducts and qualitative or quantitative changes in glandular secretions (see: Li Xun et al., "The Efficacy of Comprehensive Therapy in the Treatment of MGD Dry Eye Syndrome"). [0004] The traditional treatment for patients with MGD type dry eye is usually ...

AI Technical Summary

Problems solved by technology

[0004] The traditional treatment for patients with MGD type dry eye is usually treated by hot compress and meibomian gland forceps pressing and dredging. This treatment takes a long time, short treatment maintenance time, and poor patient compliance. Local continuous heating, limited therapeutic effect, poor patient comfort and poor treatment experience

At the same time, this treatment method has higher requirements on the doctor's technique and efficiency.

Images